Transfection of the Her-2 gene to achieve amplification in ER positive human breast cancer cells also results in acquisition of estrogen-independent growth that is resistant to therapy with the anti-estrogen tamoxifen9. This evidence concerns the gene ERBB2 and breast cancer.